⌘K
Loading ticker…
Enanta Pharmaceuticals, Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Enanta Pharmaceuticals, Inc (ENTA) has a 3-month relative strength percentile of 61 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 4.55×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
61 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ENTA is in a stage 3 topping pattern, week 3. Currently in a 124-day base; basing ADR 5.7% (broad 6.5%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 5.1% / 9.2%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ENTA is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $11M notional. Top 3 carry $23M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $11M |
| IWMiShares Russell 2000 ETF | 0.01% | $9M |
| VXFVanguard Extended Market ETF | 0.00% | $4M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $584K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ENTA Jan avg: 3.63% median: 1.81% win: 50% σ: 22.12% n: 4 2022-04-12 → 2026-05-29 | ENTA Feb avg: 18.06% median: 14.56% win: 75% σ: 25.57% n: 4 2022-04-12 → 2026-05-29 | ENTA Mar avg: -8.96% median: -14.15% win: 25% σ: 21.58% n: 4 2022-04-12 → 2026-05-29 | ENTA Apr avg: -5.10% median: -12.09% win: 40% σ: 14.40% n: 5 2022-04-12 → 2026-05-29 | ENTA May avg: -17.82% median: -9.24% win: 0% σ: 16.80% n: 5 2022-04-12 → 2026-05-29 | ENTA Jun avg: 10.26% median: 11.20% win: 75% σ: 15.99% n: 4 2022-04-12 → 2026-05-29 (current) | ENTA Jul avg: 4.84% median: 7.03% win: 75% σ: 12.96% n: 4 2022-04-12 → 2026-05-29 | ENTA Aug avg: -3.31% median: -1.17% win: 50% σ: 16.48% n: 4 2022-04-12 → 2026-05-29 | ENTA Sep avg: -4.16% median: -17.18% win: 25% σ: 31.37% n: 4 2022-04-12 → 2026-05-29 | ENTA Oct avg: -8.04% median: -10.73% win: 25% σ: 11.91% n: 4 2022-04-12 → 2026-05-29 | ENTA Nov avg: 1.48% median: 0.31% win: 50% σ: 21.58% n: 4 2022-04-12 → 2026-05-29 | ENTA Dec avg: -3.62% median: 3.49% win: 75% σ: 20.18% n: 4 2022-04-12 → 2026-05-29 |